000			03364nam a2200409 c 4500
999			_c330977 _d330977 _x1
001			330977
003			ES-MaUEC
005			20230102114635.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			210217s2021 gw | s |||| 0|eng d
020			_a9783030659080
024	7		_a10.1007/978-3-030-65908-0 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _erda _dES-MaUEC
050		4	_aRC845 _b2021 EB
245	0	0	_aDiseases of the Liver and Biliary Tree _cedited by Annarosa Floreani.
250			_aFirst edition 2021
264		1	_aCham, Switzerland _bSpringer International Publishing _c2021
300			_a1 recurso en línea (VIII, 293 páginas) _b40 ilustraciones, 21 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aPart 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.
520	3		_aThis book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.
988			_aSpringer_Medicine_2021
650		7	_2embne _9169917 _aHígado _xEnfermedades
700	1		_aFloreani, Annarosa _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030659073
776	0	8	_iPrinted edition: _z9783030659097
776	0	8	_iPrinted edition: _z9783030659103
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-65908-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2021 _dz _ea _zSI